carbamazepine has been researched along with B-Cell Leukemia in 1 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schlaifer, D | 1 |
| Arlet, P | 1 |
| Montane de la Roque, P | 1 |
| Ollier, S | 1 |
| Abbal, M | 1 |
| Le Tallec, Y | 1 |
1 other study available for carbamazepine and B-Cell Leukemia
| Article | Year |
|---|---|
Antiepileptic drug-induced lymphoproliferative disorder associated with acquired C1 esterase inhibitor deficiency and angioedema.
Topics: Aged; Angioedema; Carbamazepine; Complement C1 Inactivator Proteins; Female; Humans; Leukemia, B-Cel | 1992 |